David Sheehan

David Sheehan is the Founder, President, and CEO of Nucleus Biologics. As CEO, Dave led the development of innovative cell culture tools to simplify and accelerate the design, customization, and ordering of cell culture media products. Today, Nucleus Biologics offers a unique portfolio of products and services that can support your innovative research from discovery to commercialization. Prior to Nucleus Biologics, Dave was COO of Volcano Corporation, a publicly held life sciences company that was sold to Philips for $1.2 billion. Previous to Volcano, Dave was the CEO of Digirad, a cardiovascular imaging company that he took public in 2004, and in leadership positions at Baxter and Haemonetics. Dave holds an MBA from The Tuck School at Dartmouth College and a BS in Mechanical Engineering from Worcester Polytechnic Institute.